137 related articles for article (PubMed ID: 23225249)
1. D-chiro-inositol attenuates epinephrine-stimulated hepatic glucose output in the isolated perfused liver independently of insulin.
Whiting L; Danaher RN; Ruggiero K; Lee CC; Chaussade C; Mulvey T; Phillips A; Loomes KM
Horm Metab Res; 2013 May; 45(5):394-7. PubMed ID: 23225249
[TBL] [Abstract][Full Text] [Related]
2. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Croze ML; Soulage CO
Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
[TBL] [Abstract][Full Text] [Related]
3. Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity.
Villeneuve MC; Ostlund RE; Baillargeon JP
Metabolism; 2009 Jan; 58(1):62-8. PubMed ID: 19059532
[TBL] [Abstract][Full Text] [Related]
4. d- chiro-Inositol Ameliorates High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance via PKCε-PI3K/AKT Pathway.
Cheng F; Han L; Xiao Y; Pan C; Li Y; Ge X; Zhang Y; Yan S; Wang M
J Agric Food Chem; 2019 May; 67(21):5957-5967. PubMed ID: 31066268
[TBL] [Abstract][Full Text] [Related]
5. Interaction of sympathomimetics and insulin with hepatic glucose production by isolated perfused rat livers: effects of continuous versus pulsatile infusion.
Komjati M; Astner-Kremsmayr H; Waldhäusl W; Reitgruber W; Breitenecker F; Troch I
Endocrinology; 1988 Oct; 123(4):1798-807. PubMed ID: 3046926
[TBL] [Abstract][Full Text] [Related]
6. D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome.
Pericuesta E; Laguna-Barraza R; Ramos-Ibeas P; Gutierrez-Arroyo JL; Navarro JA; Vera K; Sanjuan C; Baixeras E; de Fonseca FR; Gutierrez-Adan A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842637
[TBL] [Abstract][Full Text] [Related]
7. Reflections on inositol(s) for PCOS therapy: steps toward success.
Nestler JE; Unfer V
Gynecol Endocrinol; 2015 Jul; 31(7):501-5. PubMed ID: 26177098
[TBL] [Abstract][Full Text] [Related]
8. Effects of dietary myo-inositol, D-chiro-inositol and L-chiro-inositol on hepatic lipids with reference to the hepatic myo-inositol status in rats fed on 1,1,1-trichloro-2,2-bis (p-chlorophenyl) ethane.
Okazaki Y; Setoguchi T; Katayama T
Biosci Biotechnol Biochem; 2006 Nov; 70(11):2766-70. PubMed ID: 17090942
[TBL] [Abstract][Full Text] [Related]
9. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.
Monastra G; Unfer V; Harrath AH; Bizzarri M
Gynecol Endocrinol; 2017 Jan; 33(1):1-9. PubMed ID: 27898267
[TBL] [Abstract][Full Text] [Related]
10. Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index.
Genazzani AD; Battipaglia C; Petrillo T; Piacquadio N; Ambrosetti F; Arnesano M; Semprini E; Sponzilli A; Tomatis V; Simoncini T
Gynecol Endocrinol; 2022 Aug; 38(8):681-688. PubMed ID: 35748584
[No Abstract] [Full Text] [Related]
11. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.
Nordio M; Proietti E
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):575-81. PubMed ID: 22774396
[TBL] [Abstract][Full Text] [Related]
12. Cucurbita ficifolia Bouché (Cucurbitaceae) and D-chiro-inositol modulate the redox state and inflammation in 3T3-L1 adipocytes.
Fortis-Barrera Á; Alarcón-Aguilar FJ; Banderas-Dorantes T; Díaz-Flores M; Román-Ramos R; Cruz M; García-Macedo R
J Pharm Pharmacol; 2013 Oct; 65(10):1563-76. PubMed ID: 24028624
[TBL] [Abstract][Full Text] [Related]
13. The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.
Chang HH; Choong B; Phillips AR; Loomes KM
Exp Biol Med (Maywood); 2015 Jan; 240(1):8-14. PubMed ID: 25060739
[TBL] [Abstract][Full Text] [Related]
14. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.
Sun TH; Heimark DB; Nguygen T; Nadler JL; Larner J
Biochem Biophys Res Commun; 2002 May; 293(3):1092-8. PubMed ID: 12051772
[TBL] [Abstract][Full Text] [Related]
15. D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.
Galazis N; Galazi M; Atiomo W
Gynecol Endocrinol; 2011 Apr; 27(4):256-62. PubMed ID: 21142777
[TBL] [Abstract][Full Text] [Related]
16. Insulin-stimulated glucose transport is dependent on Golgi function in isolated working rat heart.
Doenst T; Cedars AM; Taegtmeyer H
J Mol Cell Cardiol; 2000 Aug; 32(8):1481-8. PubMed ID: 10900174
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of d-chiro-inositol analogues with insulin-like actions.
Rendle PM; Kassibawi F; Johnston KA; Hart JB; Cameron SA; Falshaw A; Painter GF; Loomes KM
Eur J Med Chem; 2016 Oct; 122():442-451. PubMed ID: 27410479
[TBL] [Abstract][Full Text] [Related]
18. Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.
Matsuura B; Kanno S; Minami H; Tsubouchi E; Iwai M; Matsui H; Horiike N; Onji M
J Gastroenterol; 2004; 39(4):339-45. PubMed ID: 15168245
[TBL] [Abstract][Full Text] [Related]
19. The effect of insulin on epinephrine and glucagon inactivated glycogen synthetase I in the isolated perfused rat liver.
Höstmark AT
Acta Physiol Scand; 1973 Jun; 88(2):248-55. PubMed ID: 4202928
[No Abstract] [Full Text] [Related]
20. Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.
Genazzani AD; Prati A; Santagni S; Ricchieri F; Chierchia E; Rattighieri E; Campedelli A; Simoncini T; Artini PG
Gynecol Endocrinol; 2012 Dec; 28(12):969-73. PubMed ID: 22612517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
